SONAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Sonazine patents expire, and when can generic versions of Sonazine launch?
Sonazine is a drug marketed by Fosun Pharma and Chartwell Rx and is included in two NDAs.
The generic ingredient in SONAZINE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sonazine
A generic version of SONAZINE was approved as chlorpromazine hydrochloride by ZYDUS LIFESCIENCES on January 17th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SONAZINE?
- What are the global sales for SONAZINE?
- What is Average Wholesale Price for SONAZINE?
Summary for SONAZINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 129 |
Patent Applications: | 2,243 |
DailyMed Link: | SONAZINE at DailyMed |
US Patents and Regulatory Information for SONAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fosun Pharma | SONAZINE | chlorpromazine hydrochloride | CONCENTRATE;ORAL | 080983-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fosun Pharma | SONAZINE | chlorpromazine hydrochloride | CONCENTRATE;ORAL | 080983-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | SONAZINE | chlorpromazine hydrochloride | SYRUP;ORAL | 083040-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |